Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
...c patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed an oral formulation of the active ingredient in ganite that is currently undergoing initial clinical trials as a potential treatment for diseases associated with accelerated bone loss. Genta is partnered w...Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane
...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma
...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...Genta Receives Key Patent Related to Oral Gallium Compound G4544
... nitrate injection). The active ingredient in both ganite and G4544 is ionic gallium, which is reversibly in...s a mild anabolic agent to enhance bone formation. ganite is approved by the U.S. Food and Drug Administrati...ated hypercalcemia that is resistant to hydration. ganite is exclusively marketed in the U.S. by Genta and i...Specialized Genasense(R) Clinical Trials Featured at AACR Meeting
...Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma
...The Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights
... of a 1-for-6 reverse stock split on July 13, 2007.) Net product sales of ganite for the second quarter and six months ended June 30, 2008 of $0.1 million a...ynthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside...Genta Announces Second Quarter 2008 Financial Results and Conference Call
... The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia
... Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
...CLL -- Company restructures to conserve cash -- Genta will seek buyer for ganite and terminates c-myb antisense program "Genta has successfully diversifie...hetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside...Genta Announces Transfer of its Common Stock to the OTC Bulletin Board
... Company is also developing tesetaxel, a novel, orally absorbed, semi- synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...Genta Announces Pending Transfer of its Common Stock to the Over-the-Counter Bulletin Board
...e Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...Genta Restructures Operations to Focus on Priority Initiatives
... The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same drug class as paclitaxel and docetaxel. ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our webs...